Clinical Trials Browser

Phase 1 × Colorectal Neoplasms × DS-8273a × Clear all

NCT02991196 2019-02-12

Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer

Phase 1 Terminated

Gastrointestinal

Colorectal Neoplasms